Page last updated: 2024-09-04

fludalanine and Smith-Magenis Syndrome

fludalanine has been researched along with Smith-Magenis Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrientos, JC	1

Reviews

1 review(s) available for fludalanine and Smith-Magenis Syndrome

Article	Year
Sequencing of chronic lymphocytic leukemia therapies. Hematology. American Society of Hematology. Education Program, 2016, Dec-02, Volume: 2016, Issue:1 Topics: Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Proliferation; Chlorambucil; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease-Free Survival; DNA Mutational Analysis; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Rituximab; Smith-Magenis Syndrome; Tumor Suppressor Protein p53	2016

Article

Year

Sequencing of chronic lymphocytic leukemia therapies.

Hematology. American Society of Hematology. Education Program, 2016, Dec-02, Volume: 2016, Issue:1

Topics: Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Proliferation; Chlorambucil; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease-Free Survival; DNA Mutational Analysis; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Rituximab; Smith-Magenis Syndrome; Tumor Suppressor Protein p53

2016